ALISON MAXFIELD: Open Payments
NPI 1629574645 · SPOKANE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$404 in 15 payments from 8 companies in 2025. Trend: 2023 $128 · 2024 $51 · 2025 $404
Food & beverage: $329Education: $75
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 3 | $110 |
| ABBVIE INC. | 4 | $104 |
| Novartis Pharmaceuticals Corporation | 3 | $73 |
| REVANCE THERAPEUTICS, INC. | 1 | $40 |
| Amgen Inc. | 1 | $23 |
| Lilly USA, LLC | 1 | $21 |
| UCB, Inc. | 1 | $17 |
| Galderma Laboratories, L.P. | 1 | $16 |
Products named: TREMFYA, SKYRIZI, COSENTYX, DAXXIFY, OTEZLA, EBGLYSS, BOTOX, Rhapsido.
Industry payments across WA — which companies pay providers there.
